Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/30/2008CA2685056A1 Negative immunomodulation of immune responses by erp5
10/30/2008CA2684845A1 Duck embryonic derived stem cell lines for the production of viral vaccines
10/30/2008CA2684626A1 Penta-specific antibodies binding il-8, gro-alpha, gro-beta, gro-gamma and ena-78
10/30/2008CA2684555A1 Use of hemagglutinin of the african swine fever virus as an adjuvant
10/30/2008CA2684492A1 Antibodies against il-25
10/30/2008CA2684329A1 Identification and method for using the pre-ligand assembly domain of the il-17 receptor
10/30/2008CA2684323A1 Prevention and treatment of cerebral amyloid angiopathy
10/30/2008CA2684278A1 Method for inhibiting scavenger receptor-a and increasing immune response to antigens
10/30/2008CA2683520A1 Vaccination regimen for b-cell vaccines
10/30/2008CA2683079A1 Novel fully human anti-vap-1 monoclonal antibodies
10/30/2008CA2683075A1 Oil-in-water emulsion influenza vaccine
10/30/2008CA2682605A1 Single chain fc, methods of making and methods of treatment
10/30/2008CA2682390A1 Pdgfr.beta.-specific inhibitors
10/30/2008CA2682282A1 Use of an mmp28 inhibitor for increasing myelination
10/30/2008CA2665881A1 Methods for providing prophylactic surface treatment for fluid processing systems and components thereof
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
10/29/2008EP1985702A2 CPG-like nucleic acids and methods of use thereof
10/29/2008EP1985634A1 Modulators of p-selectin glycoprotein ligand 1
10/29/2008EP1985633A1 Kit of parts for the treatment of cancer or infectious diseases
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985626A1 P. gingivalis antigenic composition
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985306A2 TRX1 antibody and uses therefor
10/29/2008EP1985305A1 Duck embryonic derived stem cell lines for the production of viral vaccines
10/29/2008EP1985301A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine
10/29/2008EP1985285A2 Compositions and methods for treating lymphoma
10/29/2008EP1984522A2 Methods of increasing lymphatic function
10/29/2008EP1984405A2 Influenza antigens, vaccine compositions, and related methods
10/29/2008EP1984396A2 Inhibitors specific of presenilin-1 and their uses
10/29/2008EP1984388A2 Hpv antigens, vaccine compositions, and related methods
10/29/2008EP1984024A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
10/29/2008EP1984023A2 Soluble fragments of the sars-cov spike glycoprotein
10/29/2008EP1984022A2 Influenza vaccine
10/29/2008EP1984021A2 Viable non-toxic gram negative bacteria
10/29/2008EP1983823A1 Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration
10/29/2008EP1737958B1 Compositions and methods for inducing anti-tumor immunity
10/29/2008EP1696954B1 Vaccine composition admixed with an alkylphosphatidylcholine
10/29/2008EP1629281B1 Diagnostic method for atherosclerosis
10/29/2008EP1582218B1 Compositions for the treatment of mycobacterial infections
10/29/2008EP1509547B1 Antobodies to adipose tissues
10/29/2008EP1474067B1 One dose vaccination with i mycoplasma hyopneumoniae /i
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008EP1334119B1 Compositions and methods for modulating rsv infection and immunity
10/29/2008EP1297145B1 Streptococcus pyogenes antigen
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1255560B1 Cd40 ligand adjuvant for respiratory syncytial virus vaccine
10/29/2008EP1208217B1 Antibody dependent enhancement (ade) of alphavirus infection
10/29/2008EP1180155B1 Vector for integration of heterologous sequences into poxviral genomes
10/29/2008EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/29/2008EP1137434B1 New cancer treatments
10/29/2008EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
10/29/2008EP1076564B1 Compositions for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008EP1054693B1 Inhibitors of complement activation
10/29/2008EP1036180B1 Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd)
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0961831B1 Human endokine alpha
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008EP0660721B1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
10/29/2008EP0610250B2 Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic
10/29/2008CN101296945A Immunogenic compositions and methods of use
10/29/2008CN101296944A Engineered anti-IL-23 antibodies
10/29/2008CN101296706A Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
10/29/2008CN101296705A Solid vaccine formulation
10/29/2008CN101296695A Combinations comprising AMXAA for the treatment of cancer
10/29/2008CN101294164A Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody
10/29/2008CN101294162A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
10/29/2008CN101294159A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101294144A Type II streptococcus suis sa1KR gene knockout mutant strain, preparation method and application thereof
10/29/2008CN101293930A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101293924A Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments
10/29/2008CN101293922A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293921A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293916A Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof
10/29/2008CN101293100A P16INK4a antibody for treating cervical carcinoma
10/29/2008CN101293099A Polypeptide vaccine for resisting multiple hypotype avian influenza viruses and preparation method thereof
10/29/2008CN101293098A Recombined cattle O type foot and mouth disease virus amalgamation protein vaccine
10/29/2008CN101293097A Recombined staphylococcus aureus enterotoxin O oral preparation and application thereof
10/29/2008CN101293096A Recombined staphylococcus aureus enterotoxin N oral preparation and application thereof
10/29/2008CN101293095A Recombined staphylococcus aureus enterotoxin Q oral preparation and application thereof
10/29/2008CN101293094A Recombined staphylococcus aureus enterotoxin K oral preparation and application thereof
10/29/2008CN101293093A Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof
10/29/2008CN101293092A Recombined staphylococcus aureus enterotoxin I oral preparation and application thereof
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/29/2008CN100428966C Nasal delivery devices
10/28/2008US7442783 Natural IgM antibodies and inhibitors thereof
10/28/2008US7442779 Isolation of proteins
10/28/2008US7442775 Humanized anti-CCR2 antibodies and methods of use therefor
10/28/2008US7442761 Coronavirus amino acid sequences for use in prevention and treatment of infection and cell proliferative disorders
10/28/2008US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy
10/28/2008US7442544 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus
10/28/2008US7442534 Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
10/28/2008US7442527 Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
10/28/2008US7442523 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection
10/28/2008US7442513 Method of screening for agents that modulate a homer signaling pathway
10/28/2008US7442381 Alphavirus replicons and helper constructs
10/28/2008US7442380 Treatment of diseases caused by viral infection
1 ... 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 ... 1823